Search
for
Sort by
Research 481–510 of 1000+
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Lichen Planopilaris: Update on Diagnosis and Treatment
- The histopathologic spectrum of psoriasis
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Hypopigmented Mycosis Fungoides Treated with 308 nm Excimer Laser
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Mixing the Old with the New: Drug Repurposing for Immune Deficiency in the Era of Precision Medicine and Pediatric Genomics
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata
- 874 Chromatin architectural protein CTCF controls epidermal barrier formation, hair follicle fate maintenance and suppresses inflammatory responses in the skin epithelium
- A reasonable Response to Diphensiprone in Pediatric Alopecia Patient: A Case Report
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- The skin and obesity
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Epidemiology and burden of alopecia areata: a systematic review
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Drug eruptions in dermatology
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Oxidative stress and alopecia areata
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Cutaneous Reactions to Drugs
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy